AI
Tuesday, February 16, 2016 9:05:59 AM
February 16th,2016 RXMD Reaches Record January Revenues
RXMD Announces over 1.3 Million in revenue for January 2016, This is a increase of over 24% compared to last January. Progressive care was able to fill over 15,000 Prescriptions for the month.
RXMD begins 340B contract distribution test, everything is set for the new revenue stream to begin efficiently creating income from different markets for the company
Verified 350 Million shares O/S with over 12,000,000 shares set to be returned to progressive care.
"This is a strong start to the New Year," stated Shital Parikh Mars, COO.
Link to news: http://finance.yahoo.com/news/progressive-care-achieves-1-3-130000250.html
Due Diligence Report Updated to 1/28/2016: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120147337
Technical Analysis: Click to read:
RXMD Announces over 1.3 Million in revenue for January 2016, This is a increase of over 24% compared to last January. Progressive care was able to fill over 15,000 Prescriptions for the month.
RXMD begins 340B contract distribution test, everything is set for the new revenue stream to begin efficiently creating income from different markets for the company
Verified 350 Million shares O/S with over 12,000,000 shares set to be returned to progressive care.
"This is a strong start to the New Year," stated Shital Parikh Mars, COO.
Link to news: http://finance.yahoo.com/news/progressive-care-achieves-1-3-130000250.html
Due Diligence Report Updated to 1/28/2016: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120147337
Technical Analysis: Click to read:
My post, are done in belief, and In my own opinion. I am not responsible for any trading decisions of others, do your own due diligence and choose what you believe to be the right position is.
Let's continue to beat the market by 100 fold,
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
